kynurenine has been researched along with Dysmyelopoietic Syndromes in 1 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berthon, C | 1 |
| Fontenay, M | 1 |
| Corm, S | 1 |
| Briche, I | 1 |
| Allorge, D | 1 |
| Hennart, B | 1 |
| Lhermitte, M | 1 |
| Quesnel, B | 1 |
1 trial available for kynurenine and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
Metabolites of tryptophan catabolism are elevated in sera of patients with myelodysplastic syndromes and inhibit hematopoietic progenitor amplification.
Topics: Adult; Cell Proliferation; Cells, Cultured; Female; Hematopoietic Stem Cells; Humans; Indoleamine-Py | 2013 |